Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Epsilen Bio s.r.l.
BioCentury | May 13, 2022
Finance
In latest Italy deal, Sofinnova seeds nanodelivery start-up NanoPhoria with €3.5M
Targeted, non-viral drug delivery start-up is eighth deal for European firm’s Italy-focused Telethon Fund
BioCentury | May 9, 2022
Data Byte
Italian seed and series A financings since 2020
At least 12 Italian start-ups have attracted seed or series A funding since 2020, with Sofinnova and Claris the most active VCs
BioCentury | Apr 29, 2022
Finance
Two years into Telethon Fund, Sofinnova builds Italy portfolio as ecosystem matures
European firm’s Seghezzi: Momentum building for scientific deal flow as region draws funding, teams, infrastructure
BioCentury | Jun 19, 2020
Management Tracks
Dubovsky succeeds Fries as Novavax CMO; plus Carl June to head Ziopharm SAB, Dewpoint, FerGene, Cambrex, Adverum, Epsilen and more
Items per page:
1 - 4 of 4